Early therapy for type 2 diabetes in China
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference79 articles.
1. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group;Pan;Diabet Care,1997
2. Prevalence of diabetes among men and women in China;Yang;N Engl J Med,2010
3. Prevalence and control of diabetes in Chinese adults;Xu;JAMA,2013
4. The many faces of diabetes: a disease with increasing heterogeneity;Tuomi;Lancet,2014
5. Association of beta-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population;Bi;Diabetes Obes Metab,2012
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes;Signal Transduction and Targeted Therapy;2024-06-06
2. Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study;Journal of Diabetes;2024-05-23
3. MODY Probability Calculator Is Suitable for MODY Screening in China: A Population-based Study;Journal of the Endocrine Society;2024-03-12
4. An AI Dietitian for Type 2 Diabetes Mellitus Management Based on Large Language and Image Recognition Models: Preclinical Concept Validation Study;Journal of Medical Internet Research;2023-11-09
5. An AI Dietitian for Type 2 Diabetes Mellitus Management Based on Large Language and Image Recognition Models: Preclinical Concept Validation Study (Preprint);2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3